Published in Psychopharmacologia on January 01, 1970
Analgesic effects of branding in treatment of headaches. Br Med J (Clin Res Ed) (1981) 1.14
Placebo effect in the treatment of duodenal ulcer. Br J Clin Pharmacol (1999) 1.01
[Seasonal depression and phototherapy: problems and hypotheses]. J Psychiatry Neurosci (1995) 0.75
The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci (1974) 11.10
The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Br J Psychiatry (1976) 5.12
The Hopkins Symptom Checklist (HSCL). A measure of primary symptom dimensions. Mod Probl Pharmacopsychiatry (1974) 3.66
Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv (2000) 2.77
Short form of depression inventory: cross-validation. Psychol Rep (1974) 2.61
Psychiatric illness in family practice. J Clin Psychiatry (1980) 2.29
Ineffectiveness of progesterone suppository treatment for premenstrual syndrome. JAMA (1990) 2.26
A comparison of two psychiatric screening tests. Br J Psychiatry (1976) 2.07
Rehabilitation after anterior cruciate ligament reconstruction: a systematic review. J Bone Joint Surg Am (2012) 1.89
Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry (2001) 1.86
Difference in structure between type b and nontypable Haemophilus influenzae populations. Infect Immun (1986) 1.84
Paroxetine versus placebo: a double-blind comparison in depressed patients. J Clin Psychiatry (1992) 1.74
Comparison of two dosage regimens of fluoxetine in major depression. J Clin Psychiatry (1985) 1.72
Benzodiazepine dependence and withdrawal in elderly patients. Am J Psychiatry (1989) 1.72
Symptoms of emotional distress in a family planning service: stability over a four-week period. Br J Psychiatry (1984) 1.68
Drug treatment in depressive illness. Dis Nerv Syst (1970) 1.67
Concerns about clinical drug trials. J Clin Psychopharmacol (2000) 1.67
Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants. J Infect Dis (1999) 1.63
A comparison of paroxetine and placebo in depressed outpatients. Acta Psychiatr Scand (1993) 1.62
A broader vision for managed care, Part 1: Measuring the benefit to communities. Health Aff (Millwood) (1998) 1.51
Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. Am J Psychiatry (2001) 1.50
Neurotics who fail to take their drugs. Br J Psychiatry (1965) 1.44
The influence of topical anaesthetic agent at bronchoalveolar lavage upon cellular yield and identification and upon macrophage function. Br J Dis Chest (1986) 1.44
Maternal smoking and medical expenditures for childhood respiratory illness. Am J Public Health (1997) 1.42
After hours medical services. N Z Med J (1996) 1.40
Induction and prevention of colonic inflammation in IL-2-deficient mice. J Immunol (1997) 1.40
Out of hospital cardiac arrest. N Z Med J (1996) 1.39
Adolescent contraceptive use: comparisons of male and female attitudes and information. Am J Public Health (1980) 1.34
Long-term diazepam therapy and clinical outcome. JAMA (1983) 1.34
Assessment of dosage deviation in outpatient drug research. J Clin Pharmacol J New Drugs (1970) 1.30
Atrophy of the lateral geniculate nucleus in human glaucoma detected by magnetic resonance imaging. Br J Ophthalmol (2008) 1.29
Use of clindamycin disks To detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and children. J Clin Microbiol (2000) 1.29
The Hopkins Symptom Checklist. Assessing emotional distress in obstetric-gynecologic practice. Prim Care (1976) 1.27
Assessment of regional cerebral perfusion by 99Tcm-HMPAO SPECT in chronic fatigue syndrome. Nucl Med Commun (1992) 1.23
Psychomotor performance following the long-term use of benzodiazepines. Psychopharmacol Bull (1985) 1.23
Psychological evaluation and support in a program of in vitro fertilization and embryo transfer. Fertil Steril (1985) 1.22
Buspirone and diazepam in anxiety: a controlled study. J Clin Psychiatry (1982) 1.22
The antidepressant effect of sertraline is not enhanced by dose titration: results from an outpatient clinical trial. Int Clin Psychopharmacol (2001) 1.21
Percutaneous AngioJet thrombectomy in the management of extensive deep venous thrombosis. J Vasc Interv Radiol (2001) 1.21
Amitriptyline and trimipramine in neurotic depressed outpatients: a collaborative study. Am J Psychiatry (1970) 1.20
Age distribution of lymphocytic choriomeningitis virus serum antibody in Birmingham, Alabama: evidence of a decreased risk of infection. Am J Trop Med Hyg (1997) 1.20
A randomized, placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression. J Clin Psychiatry (1998) 1.20
A protective monoclonal antibody that reacts with a novel antigen of pneumococcal teichoic acid. Microb Pathog (1987) 1.18
Withdrawal reaction from long-term, low-dosage administration of diazepam. A double-blind, placebo-controlled case study. Arch Gen Psychiatry (1980) 1.18
Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients. J Clin Psychiatry (1994) 1.16
Strategies for treatment of generalized anxiety in the primary care setting. J Clin Psychiatry (1997) 1.16
Reliability and validity of a daily diary for premenstrual syndrome. Psychiatry Res (1996) 1.13
Drug, doctor's verbal attitude and clinic setting in the symptomatic response to pharmacotherapy. Psychopharmacologia (1966) 1.12
Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder. Am J Psychiatry (1993) 1.12
Drug effects and initial severity of symptomatology. Psychopharmacologia (1965) 1.11
Long-term benzodiazepine therapy: benefits and risks. Psychopharmacol Bull (1984) 1.11
Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis. J Vasc Interv Radiol (2000) 1.10
Chlordiazepoxide and hostility in anxious outpatients. Am J Psychiatry (1974) 1.10
Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial. Arch Gen Psychiatry (1999) 1.10
Survival of transitional cell carcinoma cases in 2 Yorkshire centres. Br J Urol (1980) 1.09
Pulmonary alveolar proteinosis presenting with pneumothorax. Clin Radiol (1967) 1.08
Prior benzodiazepine use and buspirone response in the treatment of generalized anxiety disorder. J Clin Psychiatry (2000) 1.08
Pooling 12 nomifensine studies for efficacy generalizability. J Clin Psychiatry (1984) 1.07
Angiotensin- and norepinephrine-induced myocardial lesions: experimental and clinical studies in rabbits and man. Am Heart J (1975) 1.05
Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management. Acta Psychiatr Scand Suppl (1998) 1.05
Lofepramine and imipramine in unipolar depressed outpatients. A placebo controlled study. Acta Psychiatr Scand (1982) 1.04
Long-term therapeutic use of benzodiazepines. II. Effects of gradual taper. Arch Gen Psychiatry (1990) 1.04
Isochromosome for long arm of Y chromosome in patient with Turner's syndrome and sex chromosome mosaicism (45,X-46,XYqi). J Med Genet (1969) 1.03
Naturally occurring antibodies to phosphocholine as a potential index of antibody responsiveness to polysaccharides. J Infect Dis (1987) 1.03
Comparative pharmacokinetics of bupivacaine and ropivacaine, a new amide local anesthetic. Anesth Analg (1988) 1.03
Trazodone in depressed outpatients. Am J Psychiatry (1982) 1.02
Hemodynamic evaluation of the aortoiliac system based on pharmacologic vasodilatation. Surgery (1983) 1.01
Estimation of cumulative lead releases (lead flux) from the maternal skeleton during pregnancy and lactation. J Lab Clin Med (1999) 0.99
Angelman syndrome: clinical profile. J Child Neurol (1992) 0.99
Chronic use of benzodiazepines and psychomotor and cognitive test performance. Psychopharmacology (Berl) (1986) 0.99
Small intestinal function in neoplastic disease. Br J Cancer (1967) 0.99
A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. JAMA (1995) 0.99
Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in anxious outpatients. Arch Gen Psychiatry (1986) 0.98
A placebo-controlled study of effects of oral progesterone on performance and mood. Br J Clin Pharmacol (1992) 0.97
Neurotic symptom dimensions. As perceived by psychiatrists and patients of various social classes. Arch Gen Psychiatry (1971) 0.97
Clinical effects of the 5-HT1A partial agonists in depression: a composite analysis of buspirone in the treatment of depression. J Clin Psychopharmacol (1990) 0.96
New antiarrhythmic agents. 1. Primary alpha-amino anilides. J Med Chem (1979) 0.96
Anxiolytic metabolites of progesterone: correlation with mood and performance measures following oral progesterone administration to healthy female volunteers. Neuroendocrinology (1993) 0.96
Are benzodiazepines overused and abused? Br J Clin Pharmacol (1981) 0.96
Adolescent health services and contraceptive use. Am J Orthopsychiatry (1978) 0.95
What constitutes an adequate antidepressant trial for fluoxetine? J Clin Psychiatry (1990) 0.95
Evaluation of five membrane filtration methods for recovery of Cryptosporidium and Giardia isolates from water samples. Appl Environ Microbiol (2004) 0.94
The open window of susceptibility to infection after acute exercise in healthy young male elite athletes. Exerc Immunol Rev (2010) 0.94
Comparison of the rates of exchange of lead in the blood of newly born infants and their mothers with lead from their current environment. J Lab Clin Med (1999) 0.94
Chronotropic and inotropic effects of ropivacaine, bupivacaine, and lidocaine in the spontaneously beating and electrically paced isolated, perfused rabbit heart. Reg Anesth (1992) 0.94
Differential effects of the anxiolytic drugs, diazepam and buspirone, on memory function. Br J Clin Pharmacol (1987) 0.94
Low-dose dependence in chronic benzodiazepine users: a preliminary report on 119 patients. Psychopharmacol Bull (1986) 0.94
Charity and community: the role of nonprofit ownership in a managed health care system. J Health Polit Policy Law (1996) 0.93
Bupivacaine for intercostal nerve blocks in children: blood concentrations and pharmacokinetics. Anesth Analg (1986) 0.93
Venlafaxine in the treatment of premenstrual dysphoric disorder. Obstet Gynecol (2001) 0.93
Placebo-controlled trial of venlafaxine for the treatment of major depression. J Clin Psychopharmacol (1991) 0.93
Use of buspirone in patients with generalized anxiety disorder and coexisting depressive symptoms. A meta-analysis of eight randomized, controlled studies. Neuropsychobiology (1992) 0.92
Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis. QJM (2011) 0.92
Comparison of alprazolam, imipramine, and placebo in the treatment of depression. JAMA (1983) 0.92
Use of antianxiety agents in anxious outpatients. Psychopharmacology (Berl) (1978) 0.92
Percutaneous endovascular repair of infrarenal abdominal aortic aneurysms: a feasibility study. J Vasc Surg (2000) 0.92